Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9308481 | Kidney International | 2005 | 10 Pages |
Abstract
Significant alterations in the erythrocyte-associated PAF-AH and Gpx activities related to the disease stage are observed in CKD patients. Administration of EPO prevented the reduction in enzyme activities observed during the progression of the renal insufficiency, thus preserving the erythrocyte defense mechanisms against oxidative stress.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Eleni C. Papavasiliou, Chariklia Gouva, Kostas C. Siamopoulos, Alexandros D. Tselepis,